Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

A coalition of civil society members and organisations, including MSF Access Campaign, carried out several advocacy related activities, including protests, at The 49th Union World Conference on Lung Health in The Hague, The Netherlands 24-27 October 2018.  Photos are from a protest on 24 October 2018 where activists brought attention to the drug procurement challenges countries face when they shift from Global Fund support to domestic procurement and co-financing issues. Photograph by Anna McGurk
Press release
Press release |
13 November 2018
HIV/AIDS Tuberculosis

Hundreds of thousands of people’s treatment at risk as countries ‘transition’ from Global Fund support

4 min
Pharmacy at Batangafo hospital, Central African Republic 2013. Photograph by Ton Koene
Press release
Press release |
26 October 2018
Tuberculosis
Netherlands

Rapid shift from global to national purchase of TB drugs increases risk of stockouts and use of drugs of unknown quality

9 min
Nischaya, an XDR-TB patient, looking at her TB medication at the MSF clinic in Mumbai. Photograph by Atul Loke Photograph by Atul Loke
Press release
Press release |
25 October 2018
Tuberculosis
Netherlands

Activists urge national TB programs and treatment providers to discontinue use of harmful injectable agents in TB treatment

10 min
An MSF nurse performs a TB LAM test using a patients’ urine to test the presence of TB in a severely ill AIDS patient. Photograph by Albert Masias
Press release
Press release |
25 October 2018
Tuberculosis
Netherlands

Activists call on countries and donors to immediately scale up use of life-saving TB LAM test

11 min
MSF, alongside other civil society organisations, protested against J&J during the Union Conference on Wednesday, the 24th.
Press release
Press release |
25 October 2018
Tuberculosis
Netherlands

Activists interrupt TB conference opening ceremony to call on J&J to cut price of TB drug in half, to one dollar per day

5 min
Image of bedaquiline, TB drug at the MSF project in Osh, Kyrgyzstan, 2017. Photograph by Maxime Fossat
Press release
Press release |
23 October 2018
Tuberculosis
Netherlands

MSF warns high prices of tuberculosis drugs restrict people's access to best drug-resistant TB treatment

5 min
Winile stands outside her house in the Manzini region of Swaziland Photograph by Alexis Huguet
Press release
Press release |
27 September 2018
Tuberculosis

MSF response to first-ever UN tuberculosis summit

2 min
MSF and other civil society protests in Munich at the European Patent Office against Gilead's monopoly on sofosbuvir, Germany 2018. Photograph by Peter Bauza
Press release
Press release |
26 September 2018
Hepatitis C
Brazil

Brazilian court suspends Gilead's patent on hepatitis C medicine sofosbuvir

2 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury